|
The 11th edition of Pharmac South, the premier pharmaceutical trade exhibition and conference in Southern India, is set to commence on June 4, 2026, at the Chennai Trade Centre.
Dr. Rajeev Singh Raghuvanshi, the Drugs Controller General of India (DCGI), will officially open the two-day event, underscoring the regulatory significance of the summit in the current national pharmaceutical landscape. Organized by the Tamil Nadu state board of the Indian Drug Manufacturers’ Association (IDMA) in collaboration with Orbit Exhibitors in Mumbai, the event is positioned as a pivotal platform for the pharma MSME sector.
The upcoming edition is poised to break previous records in terms of scale and industry engagement. According to Rupen Vikamsey, managing director of Orbit Exhibitors, the number of stalls and participating entities is expected to surpass all previous years. While the 2025 expo saw participation from 125 companies across India, the 2026 edition is expected to see the participation of over 150 companies. Rupen expressed the hope that, with the continued growth of the event, Pharmac South will soon rise to the level of international pharmaceutical expositions.
Echoing this optimism, J Jayaseelan, chairman of the IDMA Tamil Nadu state board, stated that the event is strategically designed to catalyze the growth of pharmaceutical industries in South India, with a particular focus on the manufacturing hub of Tamil Nadu. He pointed out that the expo serves as a vital bridge between machinery manufacturers, raw material suppliers, and finished formulation players, fostering a self-reliant ecosystem in line with national industrial goals.
A key highlight of this year’s program is the series of specialized technical sessions curated to address contemporary challenges in manufacturing and marketing. These sessions aim to equip domestic manufacturers with the necessary insights to navigate evolving global compliance standards. Jayaseelan emphasized that these knowledge-sharing modules are essential for supporting the business continuity and expansion of pharmaceutical marketers and small-to-medium scale manufacturers who form the backbone of the industry.
The inaugural day will feature a high-powered panel including Dr. S V Veeramani, past national president of IDMA, along with top regulatory officials such as S. Gurubharathi, Joint Director of Drugs Control, Tamil Nadu, and Rajasekhar, Deputy Drugs Controller (India) from the CDSCO. The presence of the DCGI at the helm of the inauguration is expected to provide an opportunity for the industry to engage with the national regulator on critical policy matters, including the implementation of revised Schedule M and digital healthcare regulations.
Beyond the technical and regulatory discourse, the event will also explore modern business dynamics. Day one will feature sessions on branding and the ‘Trust Economy’ within South Indian healthcare, led by business mentor Sivakumar Bellan and industry consultants Dr. Hari Natarajan and Dr. Karishma Atul Shah of Pronto Consult. These discussions are intended to shift the focus from traditional manufacturing toward building resilient and recognizable pharmaceutical brands in a competitive market.
The second day of the conference will focus on global trade and technical excellence, beginning with Raja Bhanu, Director General of Pharmexcil, who will address the challenges and opportunities in the changing global export landscape. This will be followed by a technical session by Dr. Kalaiselvan from the Indian Pharmacopoeia Commission (IPC) on ‘IP 2026–An Ecosystem for Strengthening the Quality of Pharmaceuticals’. The post-lunch sessions will feature keynote speakers Bharathi Bhaskar, a prominent influencer and TV personality, discussing negotiation skills, and Sujith Kumar, founder of Maatram Foundation, speaking on brand marketing. The inclusion of these diverse topics reflects the event's holistic approach to empowering the next generation of pharmaceutical professionals and entrepreneurs in the region.
|